CAS 332063-87-3

Formule : C19H13N3O3

InChI : InChI=1S/C19H13N3O3/c23-18(6-4-15-2-1-11-24-15)21-14-3-5-17-16(12-14)22-19(25-17)13-7-9-20-10-8-13/h1-12H,(H,21,23)/b6-4+

Code InChI : QSSYRORXXFTVFI-GQCTYLIASA-N

SMILES : C1=COC(=C1)/C=C/C(=O)NC2=CC3=C(C=C2)OC(=N3)C4=CC=NC=C4

SW157765

CAS : 332063-87-3

SW157765

Formule : C₁₉H₁₃N₃O₃

Degré de pureté : ≥98%

Masse moléculaire : 331.32

Ref: 54-BUP23164

SW157765

CAS : 332063-87-3

SW157765 is a glucose transporter GLUT8 inhibitor that inhibits the uptake of fluorescent 2-deoxyglucose (2DG) in SW157765-sensitized cells.

Formule : C₁₉H₁₃N₃O₃

Degré de pureté : 98.67% - 99.90%

Couleur et forme : Yellow Solid

Masse moléculaire : 331.3248

Ref: TM-T40413

3-(Furan-2-yl)-N-(2-(pyridin-4-yl)benzo[d]oxazol-5-yl)acrylamide

CAS : 332063-87-3

Formule : C₁₉H₁₃N₃O₃

Degré de pureté : 95%

Couleur et forme : Solid

Masse moléculaire : 331.3248

Ref: IN-DA023OQV

SW157765

CAS : 332063-87-3

SW157765 is a drug that has been shown to outperform other drugs in the treatment of cancer. SW157765 blocks the enzyme, acetyl-CoA carboxylase, which inhibits the production of fatty acids and prevents tumor growth. It has also been shown to sensitize cells to chemotherapy drugs and radiation therapy. SW157765 is a modular compound, meaning it can be broken down into smaller molecules for more specific treatments. The mechanism of action for SW157765 was found by studying data from clinical trials on cancer cell lung cancer. This drug works by inhibiting the biosynthesis of fatty acids, which are necessary for tumor growth. This molecule is also able to cross cellular membranes and enter cells, making it an ideal candidate for treating cancers that have spread throughout the body.

Formule : C₁₉H₁₃N₃O₃

Degré de pureté : Min. 95%

Masse moléculaire : 331.32 g/mol

Ref: 3D-HNA06387